|
Name |
Cytochalasin R1
|
Molecular Formula | C30H41NO6 | |
IUPAC Name* |
[(1R,2R,3E,5R,7S,9E,11R,12S,13R,14S,15R,16S)-16-benzyl-5,12,13-trihydroxy-5,7,13,14-tetramethyl-18-oxo-17-azatricyclo[9.7.0.01,15]octadeca-3,9-dien-2-yl] acetate
|
|
SMILES |
C[C@H]1C/C=C/[C@H]2[C@@H]([C@]([C@H]([C@@H]3[C@@]2([C@@H](/C=C/[C@](C1)(C)O)OC(=O)C)C(=O)N[C@H]3CC4=CC=CC=C4)C)(C)O)O
|
|
InChI |
InChI=1S/C30H41NO6/c1-18-10-9-13-22-26(33)29(5,36)19(2)25-23(16-21-11-7-6-8-12-21)31-27(34)30(22,25)24(37-20(3)32)14-15-28(4,35)17-18/h6-9,11-15,18-19,22-26,33,35-36H,10,16-17H2,1-5H3,(H,31,34)/b13-9+,15-14+/t18-,19-,22-,23-,24+,25-,26-,28-,29+,30+/m0/s1
|
|
InChIKey |
AVASIWUXPVFFGK-UPDPWUGUSA-N
|
|
Synonyms |
Cytochalasin R1
|
|
CAS | NA | |
PubChem CID | 139585282 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 511.6 | ALogp: | 2.9 |
HBD: | 4 | HBA: | 6 |
Rotatable Bonds: | 4 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 116.0 | Aromatic Rings: | 4 |
Heavy Atoms: | 37 | QED Weighted: | 0.363 |
Caco-2 Permeability: | -5.452 | MDCK Permeability: | 0.00002100 |
Pgp-inhibitor: | 0.782 | Pgp-substrate: | 0.928 |
Human Intestinal Absorption (HIA): | 0.862 | 20% Bioavailability (F20%): | 0.41 |
30% Bioavailability (F30%): | 0.203 |
Blood-Brain-Barrier Penetration (BBB): | 0.194 | Plasma Protein Binding (PPB): | 78.99% |
Volume Distribution (VD): | 0.465 | Fu: | 5.84% |
CYP1A2-inhibitor: | 0.021 | CYP1A2-substrate: | 0.093 |
CYP2C19-inhibitor: | 0.153 | CYP2C19-substrate: | 0.615 |
CYP2C9-inhibitor: | 0.221 | CYP2C9-substrate: | 0.181 |
CYP2D6-inhibitor: | 0.017 | CYP2D6-substrate: | 0.102 |
CYP3A4-inhibitor: | 0.849 | CYP3A4-substrate: | 0.255 |
Clearance (CL): | 2.055 | Half-life (T1/2): | 0.573 |
hERG Blockers: | 0.085 | Human Hepatotoxicity (H-HT): | 0.765 |
Drug-inuced Liver Injury (DILI): | 0.478 | AMES Toxicity: | 0.007 |
Rat Oral Acute Toxicity: | 0.573 | Maximum Recommended Daily Dose: | 0.976 |
Skin Sensitization: | 0.147 | Carcinogencity: | 0.015 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.008 |
Respiratory Toxicity: | 0.908 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
D06CWH | 0.290 | ||||||
D05VQI | 0.268 | ||||||
D03IKT | 0.257 | ||||||
D0F1EX | 0.257 | ||||||
D0E9KA | 0.253 | ||||||
D0O5WP | 0.252 | ||||||
D0R1BD | 0.252 | ||||||
D08PIQ | 0.252 | ||||||
D0V3ZA | 0.251 | ||||||
D0SP3D | 0.251 |